Newer therapeutic approaches: Inflammatory muscle disorders

Rheumatic Disease Clinics of North America

Volumn 32, Issue 1, 2006, Pages 121-128

  Di Martino, Stephen J ^a,b,c   Kagen, Lawrence J ^a,b,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETANERCEPT; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MEPREDNISONE; METHOTREXATE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD20; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; STEROID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ALOPECIA; ANTISYNTHETASE SYNDROME; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; CLINICAL FEATURE; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; DRUG SAFETY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INCLUSION BODY MYOSITIS; MUSCLE WEAKNESS; MYOSITIS; NEUROLOGIC DISEASE; NONHUMAN; PHYSIOTHERAPY; POLYMYOSITIS; PRIORITY JOURNAL; RASH; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTI-INFLAMMATORY AGENTS; HUMANS; IMMUNOLOGIC FACTORS; MYOSITIS;

EID: 33344456791     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2005.10.001     Document Type: Review

References (18)

1. H. Chinoy, W.E. Ollier, and R.G. Cooper Have recent immunogenetic investigations increased our understanding of disease mechanisms in the idiopathic inflammatory myopathies? Curr Opin Rheumatol 16 6 2004 707 713
2. M.C. Dalakas Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inculsion body myositis Curr Opin Neurol 17 5 2004 561 567
3. A. Bohan, and J. Peter Polymyositis and dermatomyositis (first of two parts) N Engl J Med 292 7 1975 344 347
4. A. Bohan, and J. Peter Polymyositis and dermatomyositis (second of two parts) N Engl J Med 292 8 1975 403 407
5. M.C. Dalakas, and R. Hohlfeld Polymyositis and dermatomyositis Lancet 362 9388 2003 971 982
6. A. Schnabel, M. Reuter, and J. Biederer Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment Semin Arthritis Rheum 32 5 2003 273 284
7. P. Fratta, W.K. Engel, and F.W. Van Leewen Mutant ubiquitin UBB+ 1 is accumulated in sporadic inclusion-body myositis muscle fibers Neurology 63 6 2004 1114 1117
8. V. Askanas, and W.K. Engel Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-beta, misfolded proteins, predisposing genes, and aging Curr Opin Rheumatol 15 6 2003 737 744
9. G.J. Hengstman, B.G. van Engelen, and W.J. van Venrooij Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations Curr Opin Rheumatol 16 6 2004 692 699
10. A.A. Amato, and R.C. Griggs Treatment of idiopathic inflammatory myopathies Curr Opin Neurol 16 5 2003 569 575
11. M.C. Dalakas Intravenous immunoglobulin in autoimmune neuromuscular diseases JAMA 291 19 2004 2367 2375
12. P. Cherin, S. Pelletier, and A. Teixeira Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients Arthritis Rheum 46 2 2002 467 474
13. S. Kuru, A. Inukai, and T. Kato Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies Acta Neuropathol (Berl) 105 3 2003 217 224
14. G.J. Hengstman, F.H. van den Hoogen, and P. Barrera Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations Eur Neurol 50 1 2003 10 15
15. I. Labioche, E. Liozon, and B. Weschler Refractory polymyositis responding to infliximab: extended follow-up Rheumatology (Oxford) 43 4 2004 531 532
16. H. Sprott, M. Glatzel, and B.A. Michel Treatment of myositis with etanercept (Enbrel), a recombinant human soluble fusion protein of TNF-alpha type II receptor and IgG1 Rheumatol 43 4 2004 524 526
17. J. Musial, A. Undas, and M. Celinska-Lowenhoff Polymyositis associated with infliximab treatment for rheumatoid arthritis Rheumatology (Oxford) 42 12 2003 1566 1568
18. T.D. Levine Rituximab in the treatment of dermatomyositis: an open-label pilot study Arthritis Rheum 52 2 2005 601 607